Seeker Biologics
Boston
About Seeker Biologics
Seeker Biologics aims to make new medicines for allergic, autoimmune and inflammatory diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $24.1M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2021)
Industries & Categories
Biopharma, Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/seeker-biologics-60649 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.